Status:
COMPLETED
Family Intervention for Chinese Americans With Type 2 Diabetes
Lead Sponsor:
NYU Langone Health
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The goal of this pilot study is to examine the feasibility and acceptability of a family-oriented SMS intervention in 30 Chinese Americans with T2D and their family members. Participants will be rando...
Detailed Description
Chinese Americans are one of the fastest growing immigrant groups in the US, who suffer disproportionately high type 2 diabetes (T2D) burden and have poorly controlled T2D. Given the high economic and...
Eligibility Criteria
Inclusion
- Inclusion criteria for patient participants:
- self-identify as Chinese or Chinese American;
- be between the ages of 18 and 70,
- self-report a diagnosis of T2D;
- be willing to receive WeChat messages regarding T2D management,
- possess a smartphone or be willing and able to use a study smartphone. If participants have their own smartphones, they are encouraged to use their own phones. For participants who do not have smartphones, the study will provide them
- has a family member or friend be willing to participate in the study to learn about T2D to better support them
- Inclusion criteria for family/friend participants: family/friend participants must
- be between 18-70 years old,
- be willing to receive WeChat messages regarding T2D management
- possess a smartphone or be willing and able to use a study smartphone. If participants have their own smartphones, they are encouraged to use their own phones. For participants who do not have smartphones, the study will provide them
Exclusion
- Exclusion criteria for both patient and family/friend participants:
- unable or unwilling to provide informed consent;
- unable to participate meaningfully in the intervention (e.g., uncorrected sight and hearing impairment);
- unwilling to accept randomization assignment;
- pregnant, plans to becomes pregnant in the next 6 months, or who become pregnant during the study, or
- breastfeeding.
Key Trial Info
Start Date :
April 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2022
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04108299
Start Date
April 21 2021
End Date
July 30 2022
Last Update
August 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016